63 N.E.3d 349
Ind. Ct. App.2016Background
- In 2012 an outbreak of fungal meningitis was traced to preservative-free methylprednisolone acetate (MPA) compounded by NECC; contaminated lots infected patients nationwide, including Indiana plaintiffs who received epidural injections.
- Plaintiffs sued two Indiana provider groups (Anonymous Clinic in St. Joseph County; OSMC and affiliates in Elkhart County), alleging negligence in choosing to administer preservative-free MPA and in failing to investigate/evaluate NECC as a supplier.
- Some plaintiffs did not follow the Indiana Medical Malpractice Act (MMA) pre-suit procedures; defendants moved to dismiss or for summary judgment arguing the claims are medical malpractice governed by the MMA.
- The Indiana Patient’s Compensation Fund (PCF) intervened, arguing the claims are general negligence (not subject to MMA). Plaintiffs ultimately agreed their claims were malpractice.
- Trial courts in both counties held the claims fall under the MMA; the Court of Appeals affirmed, concluding provider decisions to select preservative-free MPA and to source it from NECC involved professional medical judgment and thus are ‘‘health care’’ under the MMA.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether procurement/selection of preservative-free MPA and selection of NECC as supplier constitute "health care" under the MMA | Plaintiffs (and defendants at trial) conceded these are medical decisions subject to the MMA | PCF: procurement and supplier-selection are general negligence/products issues outside the MMA | Held: selection and procurement involve exercise of professional medical judgment and are "health care" under the MMA |
| Whether alleged decisions pre-dating treatment sever the causal connection to the patient–provider relationship | PCF: decisions made years earlier are not tied to individual patient care and thus outside the MMA | Defendants: general treatment-policy decisions that later affect patients are within MMA scope | Held: MMA covers acts performed for or on behalf of patients during their care; general decisions affecting later treatment can fall under MMA |
| Whether the claims can be resolved without medical expert testimony (i.e., are ordinary negligence) | PCF: issues (contaminated product) are ordinary negligence/products issues suitable for jurors | Defendants/Plaintiffs: resolving whether preservative-free MPA was the proper remedy requires medical standards and expert proof | Held: factual and causation issues require medical expertise; claims not resolvable by lay jurors alone and thus fall under MMA |
| Public‑policy/financial impact on PCF if claims are governed by MMA | PCF: applying MMA here could expose the Fund to large payouts and unintended liability for product safety | Defendants: court must apply law; funding/liquidity concerns fall to Legislature/statutory mechanisms | Held: Court applies MMA despite potential fiscal consequences; policy concerns are for the General Assembly |
Key Cases Cited
- Kondamuri v. Kondamuri, 799 N.E.2d 1153 (Ind. Ct. App.) (jurisdictional questions reviewed de novo)
- Howard Regional Health Sys. v. Gordon, 952 N.E.2d 182 (Ind. 2011) (distinguishing MMA coverage: covers curative/salutary conduct within professional capacity)
- Harts v. Caylor-Nickel Hosp., Inc., 553 N.E.2d 874 (Ind. Ct. App.) (premises/ordinary negligence outside MMA when issues are within common juror knowledge)
- Pluard ex rel. Pluard v. Patients Compensation Fund, 705 N.E.2d 1035 (Ind. Ct. App.) (equipment/maintenance issues resolvable without medical standard fall outside MMA)
- Chamberlain v. Walpole, 822 N.E.2d 959 (Ind. 2005) (MMA imposes procedural requirements and panels before filing malpractice suits)
- In re Stephens, 867 N.E.2d 148 (Ind. 2007) (explaining MMA liability caps and PCF role)